Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Point mutations in the presenilin-1 gene (PS1) are a major cause of familial Alzheimer's disease. They result in a selective increase in the production of the amyloidogenic peptide amyloid-beta(1-42) by proteolytic processing of the amyloid precursor protein (APP). Here we investigate whether PS1 is also involved in normal APP processing in neuronal cultures derived from PS1-deficient mouse embryos. Cleavage by alpha- and beta-secretase of the extracellular domain of APP was not affected by the absence of PS1, whereas cleavage by gamma-secretase of the transmembrane domain of APP was prevented, causing carboxyl-terminal fragments of APP to accumulate and a fivefold drop in the production of amyloid peptide. Pulse-chase experiments indicated that PS1 deficiency specifically decreased the turnover of the membrane-associated fragments of APP. As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, PS1 appears to facilitate a proteolytic activity that cleaves the integral membrane domain of APP. Our results indicate that mutations in PS1 that manifest clinically cause a gain of function and that inhibition of PS1 activity is a potential target for anti-amyloidogenic therapy in Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is produced by sequential β- and γ-secretase proteolytic cleavage of the amyloid precursor protein (APP) [11–17].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [13]
In the citing paper
“The three major APOE variants, APOE2, APOE3, and APOE4, differ from each other at two amino acid positions, 112 and 158, and modulate AD risk. E3 is the most common APOE variant and is considered neutral with regards to AD risk, while E4 alleles elevate AD risk and E2 reduces AD risk12,13.”
From APOE3 - R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition (2024) · cites this paper as [12]
In the citing paper
“knocking out the gene results in decreased production of both βA4(1-40) and (1-42) amyloid peptides (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“Mutations of presenilin 1 (PS1) causing Alzheimer's disease selectively increase the secretion of the amyloidogenic βA4(1-42)”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“As β- (and α-) clipping was virtually normal in neurons derived from those animals, the effect on APP processing is confined to γ-secretase activities (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834 · cited 1×
“As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription facto”
BackgroundScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921 · cited 1×
“This was confirmed using antibodies against amino-acid residues 595–612 (R1736”
MethodAmyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Skeletal and CNS Defects in Presenilin-1-Deficient Mice
Shen, J., Bronson, R. T., Chen, D. F., Xia, W., Selkoe, D. J., & Tonegawa, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80244-5 · Cited by 959
Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesoderm
Wong, P. C., Zheng, H., Chen, H., Becher, M. W., Sirinathsinghji, D. J. S., Trumbauer, M. E., Chen, H. Y., Price, D. L., Van der Ploeg, L. H. T., & Sisodia, S. S. (1997) · Nature · doi:10.1038/387288a0 · Cited by 711
Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides
Hartmann, T., Bieger, S. C., Brühl, B., Tienari, P. J., Ida, N., Allsop, D., Roberts, G. W., Masters, C. L., Dotti, C. G., Unsicker, K., et al. (1997) · Nature Medicine · doi:10.1038/nm0997-1016 · Cited by 709
Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide
Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 686
Cited by
Items 901–1,000 of 1,008
Aisen, P. S. S., Bateman, R. J., Crowther, D. C., Cummings, J., Dwyer, J. R., Iwatsubo, T., Kosco‐Vilbois, M. H., McDade, E., Mohs, R. C., Scheltens, P., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14342 · Cited by 38
Alzheimer's disease‐causing proline substitutions lead to presenilin 1 aggregation and malfunction
Ben‐Gedalya, T., Moll, L., Bejerano‐Sagie, M., Frère, S. G. A., Cabral, W. A., Friedmann‐Morvinski, D., Slutsky, I., Burstyn‐Cohen, T., Marini, J. C., & Cohen, E. (2015) · The EMBO Journal · doi:10.15252/embj.201592042 · Cited by 38
“Mutations in PS1, a multi-spanning transmembranal aspartic protease which possesses the proteolytic activity of the c -secretase complex (De Strooper et al , 1998), are accountable for the majority of familial AD cases (Bertram & Tanzi, 2008).”
Current and Emerging Pharmacological Targets for the Treatment of Alzheimer’s Disease
Morsy, A., & Trippier, P. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190744 · Cited by 38
Fatty acids increase presenilin-1 levels and γ-secretase activity in PSwt-1 cells
Liu, Y., Yang, L., Conde-Knape, K., Beher, D., Shearman, M. S., & Shachter, N. S. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400317-jlr200 · Cited by 35
Wang, Y., Zhang, J., Du, X., Zhao, L., Tian, Q., Zhu, L., Wang, S., & Wang, J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05578.x · Cited by 37
“Amyloid plaques are composed primarily of b-amyloid (Ab)40 and Ab42, which is derived from the amyloid precursor protein (APP) by sequential proteolysis catalyzed (De Strooper et al. 1998; Vassar et al. 1999).”
BackgroundSingh, R. R. P., Barman, A., & Prabhakar, R. S. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp811154w · Cited by 40
Galveston Brain Injury Conference 2010: Clinical and Experimental Aspects of Blast Injury
Masel, B. E., Bell, R. S., Brossart, S., Grill, R. J., Hayes, R. L., Levin, H. S., Rasband, M. N., Ritzel, D. V., Wade, C. E., & DeWitt, D. S. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2011.2258 · Cited by 38
Dynamic Nature of presenilin1/γ-Secretase: Implication for Alzheimer’s Disease Pathogenesis
Zoltowska, K. M., & Berezovska, O. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0487-5 · Cited by 40
Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques
Shepherd, C. E., Gregory, G. C., Vickers, J. C., Brooks, W. S., Kwok, J. B. J., Schofield, P. R., Kril, J. J., & Halliday, G. M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.10.008 · Cited by 35
“In PS-1 AD, these protein changes are thought to occur due to abnormal gamma-secretase cleavage of Abeta, and it has been hypothesised that PS-1 may itself be the gamma-secretase enzyme (Citron et al., 1997; De Strooper et al., 1998).”
BackgroundGenetic risk factors in familial Alzheimer's disease
Sorbi, S., Forleo, P., Tedde, A., Cellini, E., Ciantelli, M., Bagnoli, S., & Nacmias, B. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00308-6 · Cited by 39
Gene-Targeting Technologies for the Study of Neurological Disorders
Beglopoulos, V., & Shen, J. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:6:1:013 · Cited by 41
“PS1 and PS2 are components of a catalytic complex with γ-secretase activity responsible for the proteolytic cleavage of various proteins, including APP and the Notch receptors (De Strooper et al., 1998, 1999).”
BackgroundThe Functions of the Amyloid Precursor Protein Gene
Panegyres, P. K. (2001) · Reviews in the Neurosciences · doi:10.1515/revneuro.2001.12.1.1 · Cited by 36
Paganelli, A. R., Ocaña, O. H., Prat, M. I., Franco, P. G., López, S. L., Morelli, L., Adamo, A. M., Riccomagno, M. M., Matsubara, E., Shoji, M., et al. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00458-0 · Cited by 41
“Deletion of Ps1 greatly reduces gsecretase activity in mice (De Strooper et al., 1998), and recent evidences indicated that presenilins may contain the active site (Li et al., 2000).”
Identification of syntaxin 1A as a novel binding protein for presenilin-1
Smith, S. K. F., Anderson, H. A., Yu, G., Robertson, A., Allen, S. J., Tyler, S. J., Naylor, R. L., MASON, G. G. F., Wilcock, G., Roche, P. A., et al. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00079-6 · Cited by 41
Physiologic and Pathologic Events Mediated by Intramembranous and Juxtamembranous Proteolysis
Golde, T. E., & Eckman, C. B. (2003) · Science's STKE · doi:10.1126/stke.2003.172.re4 · Cited by 36
Expression of Presenilin 1 in nervous system during rat development
Moreno-Flores, M. T., Medina, M., & Wandosell, F. G. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990809)410:4<556::aid-cne4>3.0.co;2-q · Cited by 36
Secretases as therapeutic targets for the treatment of Alzheimer's disease
Dominguez, D. I., Strooper, B. D., & Annaert, W. G. (2001) · Amyloid · doi:10.3109/13506120109007356 · Cited by 46
Self-citationCampbell, W. A., Reed, M. L. O., Strahle, J., Wolfe, M. S., & Xia, W. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01799.x · Cited by 35
“…in transmem- brane (TM) domains 6 and 7 of PS1 or PS2 are mutated in cultured cells (Steiner et al. 1999b; Wolfe et al. 1999a; Kimberly et al. 2000) and in transgenic mice (Xia et al. 2002), and there is no Ab production in PS knockout neurons (De Strooper et al. 1998; Herreman et al. 2000).”
BackgroundKuzuya, A., Zoltowska, K. M., Post, K. L., Arimon, M., Li, X., Svirsky, S. E., Maesako, M., Muzikansky, A., Gautam, V., Kovacs, D. M., et al. (2016) · BMC Biology · doi:10.1186/s12915-016-0248-3 · Cited by 40
“secretase complex [1, 2] involved, together with βsecretase 1 (BACE1) [3], in amyloid precursor protein (APP) processing and amyloid β (Aβ) production.”
BackgroundFreeman, J. L., & Kiper, K. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210524155944 · Cited by 35
“generated a stable tauopathy model [72].”
Huang, D., Yu, X., Yu, W.-J., Zhang, X., Liu, C., Liu, H., Sun, Y., & Jiang, Z. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.834962 · Cited by 37
Degradation of nicastrin involves both proteasome and lysosome
He, G., Qing, H., Tong, Y., Cai, F., Ishiura, S., & Song, W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04449.x · Cited by 43
Lee, J., Song, L., Terracina, G., Bara, T. A., Josien, H. B., Asberom, T., Sasikumar, T., Burnett, D. A., Clader, J. W., Parker, E. M., et al. (2011) · Biochemistry · doi:10.1021/bi200026m · Cited by 36
Tay, W. M., da Silva, G. F. Z., & Ming, L. (2013) · Inorganic Chemistry · doi:10.1021/ic301832p · Cited by 36
The secretases of Alzheimer's disease
Wolfe, M. S. (2003) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(03)54011-x · Cited by 35
The Role of Proteolysis in Alzheimer’s Disease
Hooper, N. M., Trew, A. J., Parkin, E. T., & Turner, A. J. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46826-3_39 · Cited by 38
Suga, K., Tomiyama, T., Mori, H., & Akagawa, K. (2004) · Biochemical Journal · doi:10.1042/bj20040618 · Cited by 37
Cappai, R., & White, A. R. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00027-8 · Cited by 47
Nowotny, P., Gorski, S. M., Han, S. W., Philips, K., Ray, W. J., Nowotny, V., Jones, C. J., Clark, R. F., Cagan, R. L., & Goate, A. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0805 · Cited by 37
Beglopoulos, V., & Shen, J. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.010 · Cited by 35
BACE1 interacts with nicastrin
Hattori, C., Asai, M., Oma, Y., Kino, Y., Sasagawa, N., Saido, T. C., Maruyama, K., & Ishiura, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00351-0 · Cited by 35
“Both the C-terminal fragments, C83 and C99, are substrates for c-secretase, which clips in the middle of their transmembrane regions [6,7].”
BackgroundPradier, L., Carpentier, N., Delalonde, L., Clavel, N., Bock, M., Buée, L., Mercken, L., Tocqué, B., & Czech, C. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0212 · Cited by 37
“Additionally, in eurons of PS1-KO mice, production of Ab is drastially reduced (De Strooper et al., 1998).”
BackgroundPimenova, A. A., & Goate, A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104785 · Cited by 35
Sharp, F. R., DeCarli, C. S., Jin, L., & Zhan, X. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1096206 · Cited by 37
Transcriptional regulation of the presenilin-1 gene: implication in Alzheimer's disease
Hriday, K. D. (2007) · Frontiers in bioscience · doi:10.2741/2723 · Cited by 36
“activity is greatly reduced and secretion of Aβ40 is strongly inhibited in brain cultures from living PS1embryos suggesting a direct role of PS1 in the amyloidogenic processing of APP (54).”
BackgroundThe Mitochondrial Secret(ase) of Alzheimer's Disease
Young, K. J., & Bennett, J. P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100360 · Cited by 36
“Discovery of PS1 as the catalytic enzyme responsible for Aβ generation occurred when PS1-/-mice were found to have decreased Aβ levels, in addition to altered skeletal and brain development [73].”
BackgroundLattanzio, F., Carboni, L., Carretta, D., Rimondini, R., Candeletti, S., & Romualdi, P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.017 · Cited by 38
An Alzheimer's disease hypothesis based on transcriptional dysregulation
Robakis, N. K. (2003) · Amyloid · doi:10.3109/13506120309041729 · Cited by 35
Dunys, J., Kawarai, T., Sévalle, J., Dolcini, V., George‐Hyslop, P. S., da Costa, C. A., & Checler, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611572200 · Cited by 38
Brown, J. T., Richardson, J. C., Collingridge, G. L., Randall, A. D., & Davies, C. H. (2005) · Hippocampus · doi:10.1002/hipo.20036 · Cited by 36
“…by the sequential cleavage of the amyloid precursor protein (APP) by a -secretase protein, recently identified as BACE1 (Hussain et al., 1999; Vassar et al., 1999), and the -secretase complex, which contains presenilin-1 and nicastrin (De Strooper et al., 1998; Xia et al., 1998; Yu et al., 2000).”
Huang, X., Yee, B. K., Nag, S., Chan, S. T. H., & Tang, F. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00242-5 · Cited by 36
Notch/LIN-12 signaling: transduction by regulated protein slicing
Kimble, J. E., Henderson, S., & Crittenden, S. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01263-8 · Cited by 34
Jacobsen, H., Reinhardt, D., Brockhaus, M., Bur, D., Kocyba, C., Kurt, H., Grim, M. G., Baumeister, R., & Loetscher, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35233 · Cited by 34
Steinacker, P., Hendrich, C., Sperfeld, A., Jesse, S., Lehnert, S., Pabst, A., Arnim, C. A. F. V., Mottaghy, F. M., Uttner, I., Tumani, H., et al. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0271-4 · Cited by 37
“Cleavage by b secretase leads to the generation of sAPPb and subsequently, after cleavage by c secretase, to Ab peptides, that are secreted into the CSF (De Strooper et al. 1998, Hussain et al. 1999, Seubert et al. 1992, Sinha and Lieberburg 1999, Vassar et al. 1999).”
BackgroundGenetic variants associated with neurodegenerative Alzheimer disease in natural models
Salazar, C., Valdivia, G., Ardiles, Á. O., Ewer, J., & Palacios, A. G. (2016) · Biological Research · doi:10.1186/s40659-016-0072-9 · Cited by 36
“Presenilins are catalytic proteins of γ-secretase complexes responsible for producing Aβ from APP [52]; thus, mutations in PSEN1 and PSEN2 affect the generation of Aβ peptide [13, 22, 27, 35, 40, 95].”
BackgroundAkbari, Y., Hitt, B. D., Murphy, M. P., Dagher, N. N., Tseng, B. P., Green, K. N., Golde, T. E., & LaFerla, F. M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.136 · Cited by 33
Statin treatment and a disease-specific pattern of β-amyloid peptides in Alzheimer’s disease
Höglund, K., Syversen, S., Lewczuk, P., Wallin, A., Wiltfang, J., & Blennow, K. (2005) · Experimental Brain Research · doi:10.1007/s00221-005-2243-8 · Cited by 36
“…the c-secretase is not known, but accumulating evidence suggests that the c-secretase is a high molecular weight complex formed by several proteins—APH1b, PEN2, Nicastrin and PS1 (Yu et al 2000)—and PS1 has been identified as an essential cofactor for c-secretase activity (De Strooper et al 1998).”
Backgroundγ-Secretase: characterization and implication for Alzheimer disease therapy
Xu, M., Lai, M., Huang, Q., DiMuzio‐Mower, J., Castro, J. L., Harrison, T., Nadin, A. J., Neduvelil, J. G., Shearman, M. S., Shafer, J. A., et al. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00126-4 · Cited by 37
“Second, isolated cultured neurons derived from PS1-deficient mice show the accumulation of - and -C-terminal fragments and the reduction of -secretase mediated cleavage [4,21].”
BackgroundXia, X., Wang, P., Sun, X., Soriano, S., Shum, W.-K., Yamaguchi, H., Trumbauer, M. E., Takashima, A., Koo, E. H., & Zheng, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132045399 · Cited by 33
Maldonado, T. A., Jones, R. E., & Norris, D. O. (2002) · Journal of Neurobiology · doi:10.1002/neu.10090 · Cited by 38
A short cut to the nucleus: Notch signalling
Lewis, J. H. (1998) · Nature · doi:10.1038/30597 · Cited by 33
Insights into Aβ and Presenilin from a Canine Model of Human Brain Aging
Head, E., & Torp, R. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0476 · Cited by 37
Naguib, S., Lopez-Lee, C., Torres, E. R., Lee, S.-I., Zhu, J., Zhu, D., Ye, P., Norman, K., Zhao, M., Wong, M. Y., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.05.023 · Cited by 32
Van Uden, E., Carlson, G., St. George-Hyslop, P., Westaway, D., Orlando, R., Mallory, M., Rockenstein, E., & Masliah, E. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0772 · Cited by 32
Hui, J., Feng, G., Zheng, C., Jin, H. M., & Jia, N. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.10.030 · Cited by 36
TMP21 degradation is mediated by the ubiquitin‐proteasome pathway
Liu, S., Bromley‐Brits, K., Xia, K., Mittelholtz, J., Wang, R., & Song, W. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06497.x · Cited by 35
“A direct role of PS1 in c-secretase cleavage was suggested by the reduced Ab production and increased accumulation of APP CTFs in PS1-null cells (De Strooper et al., 1998; Naruse et al., 1998; Zhang et al., 2000).”
BackgroundIdentification of an Archaeal Presenilin-Like Intramembrane Protease
Torres-Arancivia, C., Ross, C. M., Chavez, J., Assur, Z., Dolios, G., Mancia, F., & Ubarretxena‐Belandia, I. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013072 · Cited by 32
“Subsequent studies demonstrated that presenilins constituted the catalytic core of c-secretase [14,15], a multi-protein complex [16]”
BackgroundTMP21 Transmembrane Domain Regulates γ-Secretase Cleavage
Pardossi‐Piquard, R., Böhm, C., Chen, F., Kanemoto, S., Checler, F., Schmitt‐Ulms, G., George‐Hyslop, P. S., & Fraser, P. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.059345 · Cited by 32
What Can Rodent Models Tell Us About Cognitive Decline in Alzheimer's Disease?
Davis, S., & Laroche, S. (2003) · Molecular Neurobiology · doi:10.1385/mn:27:3:249 · Cited by 38
Toglia, P. T., & Ullah, G. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2015.11.1670 · Cited by 32
EVALUATION OF HOW CIGARETTE SMOKE IS A DIRECT RISK FACTOR FOR ALZHEIMER'S DISEASE
Giunta, B. N., Deng, J., Jin, J., Sadic, E., Rum, S., Zhou, H., Sanberg, P. R., & Tan, J. (2012) · Technology & Innovation · doi:10.3727/194982412x13378627621752 · Cited by 35
“Intra-cellularly, β-CTF is then cleaved by a multiprotein γ-secretase complex that results in generation of the Aβ peptide and a smaller γ-CTF (11,50).”
BackgroundSignal peptide peptidase and SPP-like proteases - Possible therapeutic targets?
Mentrup, T., Loock, A.-C., Fluhrer, R., & Schröder, B. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.06.007 · Cited by 39
Protein markers for Alzheimer disease in the frontal cortex and cerebellum
Verdile, G., Gnjec, A., Miklossy, J., Fonte, J., Veurink, G., Bates, K., Kakulas, B., Mehta, P. D., Milward, E. A., Tan, N., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000141848.45315.a6 · Cited by 32
Genetic and biochemical markers for Alzheimer's disease: recent developments
Mulder, C., Scheltens, P., Visser, J. J., van Kamp, G. J., & Schutgens, R. B. H. (2000) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563001899898 · Cited by 35
Lakowski, B., Eimer, S., Göbel, C., Böttcher, A., Wagler, B., & Baumeister, R. (2003) · Development · doi:10.1242/dev.00429 · Cited by 37
Linking molecular motors to Alzheimer’s disease
Stokin, G. B., & Goldstein, L. S. B. (2006) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2005.12.085 · Cited by 37
Inhibition of neurite outgrowth by familial Alzheimer's disease-linked presenilin-1 mutations
Dowjat, W. K., Wısnıewskı, T., Efthimiopoulos, S., & Wísniewski, H. M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00351-1 · Cited by 32
Screening for Presenilin Inhibitors Using the Free-Living Nematode, Caenorhabditis elegans
Ellerbrock, B. R., Coscarelli, E. M., Gurney, M. E., & Geary, T. G. (2004) · SLAS DISCOVERY · doi:10.1177/1087057103261038 · Cited by 32
“Multiple presenilin mutations are associated with autosomaldominant forms of familial AD and are characterized by increased relative abundance of amyloidogenic fragments of APP.3 These data were interpreted to support the concept that amino acid substitutions generate gain-of-function mutations in presenilin.8 Subsequ…”
BackgroundThe Role of Alzheimer's Disease-Related Presenilin 1 in Intercellular Adhesion
Singh, N., Talalayeva, Y., Tsiper, M. V., Romanov, V., Dranovsky, A., Colflesh, D., Rudamen, G., Vitek, M. P., Shen, J., Yang, X., et al. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5098 · Cited by 35
Biology of presenilins as causative molecules for Alzheimer disease
Nishimura, M., Yu, G., & George‐Hyslop, P. S. (1999) · Clinical Genetics · doi:10.1034/j.1399-0004.1999.550401.x · Cited by 32
“Second, PS1-deficient mice have a defect in bAPP processing manifested by the failure of g-secretase cleavage (27).”
BackgroundScorer, C. A. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02042-6 · Cited by 36
Capacitative Calcium Entry Induces Hippocampal Long Term Potentiation in the Absence of Presenilin-1
Ris, L., Dewachter, I., Reversé, D., Godaux, E., & LEUVEN, F. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300971200 · Cited by 33
Khan, A. A., Ali, R. H., & Mirza, B. (2020) · Journal of Molecular Evolution · doi:10.1007/s00239-020-09966-w · Cited by 31
“Presenilin proteins are the major catalytic component of Gamma secretase, a multi-complex protease involved in the catalysis of many membrane proteins (De Strooper et al., 1998; Zhang et al., 2000).”
BackgroundTargeting S100B in Cerebral Ischemia and in Alzheimer's Disease
Mori, T., Asano, T., & Town, T. (2010) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2010/687067 · Cited by 36
Aggregation and Fibril Structure of AβM01–42 and Aβ1–42
Silvers, R., Colvin, M. T., Frederick, K. K., Jacavone, A. C., Lindquist, S. L., Linse, S. S., & Griffin, R. G. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00729 · Cited by 34
The Complex Work of Proteases and Secretases in Wallerian Degeneration: Beyond Neuregulin-1
Pellegatta, M., & Taveggia, C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00093 · Cited by 32
Boeddrich, A., Haenig, C., Neuendorf, N., Blanc, E., Ivanov, A., Kirchner, M., Schleumann, P., Bayraktaroğlu, I., Richter, M., Molenda, C., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01206-2 · Cited by 39
Dong, J.-J., Li, Q., Wang, S.-F., Li, C., Zhao, X., Qiu, H., Zhao, M., & Zhu, H. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob40776d · Cited by 31
Ludtmann, M. H. R., Otto, G. P., Schilde, C., Chen, Z.-H., Allan, C. Y., Brace, S., Beesley, P. W., Kimmel, A. R., Fisher, P. R., Killick, R., et al. (2014) · Journal of Cell Science · doi:10.1242/jcs.140939 · Cited by 35
“It is from APP that b-amyloid (Ab), the likely causative agent of both the familial and sporadic forms of Alzheimer’s disease, is derived (De Strooper et al., 1998; Herreman et al., 2000).”
BackgroundSpecificity of presenilin‐1‐ and presenilin‐2‐dependent γ‐secretases towards substrate processing
Stanga, S., Vrancx, C., Tasiaux, B., Marinangeli, C., Karlström, H., & Kienlen‐Campard, P. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13364 · Cited by 36
“Our work confirms, both in single-KO and rescued cells, that APP substrates are more efficiently processed by PS1 than by PS2 and this is in line with published results showing a predominant implication of PS1 in the c-secretase activity [21, 22, 32, 33].”
ResultTesco, G., Ginestroni, A., Hiltunen, M., Kim, M., Dolios, G., Hyman, B. T., Wang, R., Berezovska, O., & Tanzi, R. E. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03381.x · Cited by 30
“In addition to APP and Notch (De Strooper et al. 1998, 1999; Struhl and Greenwald 1999), several additional transmembrane proteins have been identified as c-secretase substrates (De Strooper 2003; Haass 2004; Kopan and Ilagan 2004), suggesting a role of presenilins/c-secretase in the cleavage of…”
Background[Plasma beta-endorphin and stress hormones in stress and adaptation].
Lishmanov, I. B., Trifonova, Z. V., Tsibin, A. N., Maslova, L. V., & Dement'eva, L. A. (1987) · PubMed · Cited by 36
Notch is required for outgrowth of the Xenopus tail bud
Beck, C. W., & Slack, J. M. W. (2002) · The International Journal of Developmental Biology · doi:10.1387/ijdb.11934154 · Cited by 34
Dead end for neurodegeneration?
Haass, C. (1999) · Nature · doi:10.1038/20314 · Cited by 31
A presenilin‐independent aspartyl protease prefers the γ‐42 site cleavage
Lai, M., Crouthamel, M., DiMuzio, J. M., Pietrak, B., Donoviel, D. B., Bernstein, A., Gardell, S. J., Li, Y., & Hazuda, D. J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03528.x · Cited by 31
Ou-Yang, M.-H., & Van Nostrand, W. E. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-134 · Cited by 30
“Aβ is a 38–43 peptide produced from the sequential proteolysis of the amyloid precursor protein (ΑβPP), a ubiquitously expressed type I membrane protein, by β secretase [1] and γ secretase [2,3].”
Backgroundde Almeida, N. E. C., Do, T. D., LaPointe, N. E., Jhatro, M., Feinstein, S. C., Shea, J., & Bowers, M. T. (2016) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2016.09.018 · Cited by 33
Pigment Epithelium-Derived Factor Plays a Role in Alzheimer's Disease by Negatively Regulating Aβ42
Huang, M., Qi, W., Fang, S., Jiang, P., Yang, C., Mo, Y., Dong, C., Li, Y., Zhong, J., Cai, W., et al. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0628-1 · Cited by 30
“generation [9, 11] and ultimately leads to AD [12, 13].”
BackgroundADAM10 in Synaptic Physiology and Pathology
Musardo, S., Marcello, E. E., Gardoni, F., & Luca, M. D. (2013) · Neurodegenerative Diseases · doi:10.1159/000354233 · Cited by 30
Rahman, M. M., Zhang, Z., Mody, A. A., Su, D., & Das, H. K. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.066 · Cited by 30
“PS1 or PS2 containing γ-secretase has been implicated in the development of AD because of its role in the cleavage of the β-amyloid precursor protein (APP) and the production of Aβ peptide which is central to the pathogenesis of AD (De Strooper et al., 1998).”
BackgroundPardossi‐Piquard, R., Dunys, J., Giaime, E., Guillot‐Sestier, M., George‐Hyslop, P. S., Checler, F., & da Costa, C. A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05952.x · Cited by 33
“(2009) 109, 225–237 225 c-secretase activity could be presenilin-dependent (De Strooper et al. 1998) or PS-independent (Armogida et al. 2001; Lai et al. 2006).”
siRNA against presenilin 1 (PS1) down regulates amyloid β42 production in IMR-32 cells
Kandimalla, R. J. L., Wani, W. Y., Binukumar, B. K., & Gill, K. D. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-2 · Cited by 31
“This proteolysis leads to membrane shedding of the large luminal/ extracellular APP domain.”
BackgroundInfluentialToglia, P. T., & Ullah, G. (2016) · Cell Calcium · doi:10.1016/j.ceca.2016.05.002 · Cited by 31
Guix, F. X. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24526 · Cited by 32
“APP‐CTF is then cleaved by the γ‐secretase complex, with presenilin in the catalytic center, to generate Aβ peptides of distinct lengths (De Strooper et al., 1998; Wolfe et al., 1999).”
BackgroundPresenilin/γ-secretase and inflammation
Saura, C. A. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00016 · Cited by 34
“…essential for generation and accumulation of Aβ, as evidenced by the lack of Aβ production in cells derived from PS1 and PS1/PS2 defi cient mice (De Strooper et al., 1998; Zhang et al., 2000) and the absence of Aβ accumulation and amyloid plaques in the brain of APP transgenic mice lacking PS1…”
Hoos, M. D., Ahmed, M., Smith, S. O., & Nostrand, W. E. V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m603494200 · Cited by 34
Age stratification corrects bias in estimated hazard of APOE genotype for Alzheimer's disease
Liu, L., & Caselli, R. J. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.09.006 · Cited by 29
A non-human primate model of familial Alzheimer’s disease
Sato, K., Sasaguri, H., Kumita, W., Inoue, T., Kurotaki, Y., Nagata, K., Mihira, N., Sato, K., Sakuma, T., Yamamoto, T., et al. (2020) · doi:10.1101/2020.08.24.264259 · Cited by 29
Rudan Njavro, J., Klotz, J., Dislich, B., Wanngren, J., Shmueli, M. D., Herber, J., Kuhn, P., Kumar, R., Koeglsperger, T., Conrad, M., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902347r · Cited by 28
APOE3 - R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition
Naguib, S., Lopez-Lee, C., Torres, E. R., Lee, S.-I., Zhu, J., Zhu, D., Ye, P., Norman, K., Zhao, M., Wong, M. Y., et al. (2024) · doi:10.1101/2024.04.25.591140 · Cited by 25
“Mutations on presenilin 1 ( PSEN1) cause early onset autosomal dominant AD (ADAD) as early as 30-40 years of age 6 .”
Metadata
- Authors
- De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- University of Göttingen (DE)
- Venue
- Nature
- Published
- 1998-01
- Volume
- 391
- Issue
- 6665
- Pages
- 387-390
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1655404681
- Cited by
- 1,818
- References
- 30
- Citations by year
- 2026: 19 · 2025: 39 · 2024: 47 · 2023: 42 · 2022: 33 · 2021: 35 · 2020: 53 · 2019: 43 · 2018: 36 · 2017: 58 · 2016: 60 · 2015: 43 · 2014: 55 · 2013: 64 · 2012: 71
- FWCI
- 76.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- presenilin 1, amyloid precursor protein, APP processing, gamma-secretase, amyloid-beta 42, Alzheimer's disease, familial Alzheimer's disease, carboxyl-terminal fragment, gain-of-function, membrane proteolysis
- MeSH terms
- Animals, Cells, Cultured, Humans, Membrane Proteins, Neurons, Peptide Fragments, Endopeptidases, Protein Processing, Post-Translational, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Point Mutation, Mice, Presenilin-1, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.